ABOUT THE COMPETITION

The aim of the Canada-Israel Cardiovascular Innovation Forum is to:

  • To encourage early/mid-stage innovations in cardiovascular devices and digital heart health in Canada and Israel

  • To establish collaboration between Israel and Canada in developing and funding cardiovascular innovations through competitions

  • To grow network of interested investors and provide a vehicle for joint funding of promising early/mid-stage projects and companies

  • To provide young innovators an education experience in early/mid-stage company development

AREAS OF INTEREST

Early/mid-stage companies with projects in either cardiovascular devices or digital heart health are invited to submit applications in the following 3 categories of fundraising: <$500k (e.g. Proof of Principle); $500k-$1M (e.g. Preclinical studies); and >$1M (e.g. First-in-Human Studies).  

  • Judging panels from each country will assess the projects of the other country.

  • The top rated projects from Israel and Canada in each category will present for 15 minutes, followed by a 5 minute question session on April 25, 2021. Please click here to register for the event.

  • Investors interested in cardiovascular innovations in both countries will be invited to attend the presentations virtually and to contact the companies of interest after the presentation. 

  • There will be no application charges or attendance fees.

  • Canada-Israel Cardiovascular Innovation Forum does not commit funding to any applying group presenting at the forum, is not responsible for the statements of any group and does not bear any legal or financial responsibility for arrangements between investors and presenters that result from the Forum.

ELIGIBILITY & FUNDING REQUEST

Eligibility:

  • Small and Medium Enterprises (SMEs) in the cardiovascular medical device or digital heart health fields

 

Fund Request:​

  • Specify threshold: <$500k (e.g. Proof-of-Concept); $500k-$1M (e.g. Preclinical Testing); or >$1M (e.g. First-in-Human Trials)

  • Budget should carefully itemize current funding request and time period

  • Milestones to assess progress are required 

REVIEW CRITERIA & REPORTING REQUIREMENTS

Applications will be reviewed on the following criteria:

  • Novelty of innovation

  • Commercialization potential

  • Cardiovascular disease target

 

Reporting Requirement:​

timeline.png

TIMELINES

March 2, 2021:

  • Announcement of Competition

April 1, 2021:

  • Deadline for Application (5 PM EST; Midnight Israel Time)

April 12, 2021:

  • Announcement of Presenting Companies

April 25, 2021:

APPLICATION DETAILS

Application deadline is April 1, 2021 at midnight Israel time, 5:00 PM Eastern time.

Late or incomplete applications will not be considered.

 

Completed applications should be submitted electronically to the Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (hsrl.centre@utoronto.ca).

APPLY NOW

CLICK HERE to download the competition's terms of reference
 

CLICK HERE to download the application form

apply-now (1).jpg

-